Ledger.Open graph →
SEC Form D · filed August 14, 2013

Focal Point Pharmaceuticals, Inc

Offering
$150K
Sold
$150K
Exemption
—
Industry
Pharmaceuticals
Location
MEMPHIS, TN
Type
—

People & firms on this filing (4)

Scott Langille · Burlington, Ontario, CanadaExec · DirectorRaymond Stone · Burlington, Ontario, CanadaExec · DirectorGavin J. Saitowitz · New York, NYExec · DirectorCisco J. Del Valle · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗